This device is used for treatment not diagnosis.The ventricular assist system is indicated for use as a bridge to cardiac transplantation and destination therapy in patients who are at risk of death from refractory end-stage left ventricular heart failure.The system is designed for in-hospital and out-of-hospital settings.Product event summary: with a review of the available information there is no evidence to indicate any device malfunctions or performance issues that would impact the reported events.Possible clinical factors that may have contributed to this event include the patient¿s pre-existing history and related comorbidities, the progression of their underlying disease, issues related to the therapeutic use of anticoagulant and antiplatelet medications and the patient's complex post-operative course.There are possible patient, pharmacological and procedural factors that may have contributed to this event.This information is based entirely on journal literature.This event occurred outside of the us.All information provided is included in this report.Patient information is limited due to confidentiality concerns.Referenced article: factors related to the severity of early postoperative infection after heart transplantation in patients surviving prolonged mechanical support periods: experience at a single university, 2018.Journal of cardiothoracic and vascular anesthesia 2018.Doi.Org/10.1053/j.Jvca.2017.07.004.If information is provided in the future, a supplemental report will be issued.
|